Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Revenue: 2019-2025

Historic Revenue for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to -$42,000.

  • Neurogene's Revenue fell 121.05% to -$42,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$610,000, marking a year-over-year increase of 47.91%. This contributed to the annual value of $925,000 for FY2024, which is 3403.57% up from last year.
  • Per Neurogene's latest filing, its Revenue stood at -$42,000 for Q3 2025, which was up 43.24% from -$74,000 recorded in Q2 2025.
  • In the past 5 years, Neurogene's Revenue ranged from a high of -$3,000 in Q1 2023 and a low of -$602,000 during Q1 2024.
  • Its 3-year average for Revenue is -$162,909, with a median of -$42,000 in 2025.
  • In the last 5 years, Neurogene's Revenue slumped by 19,966.67% in 2024 and then skyrocketed by 86.71% in 2025.
  • Over the past 3 years, Neurogene's Revenue (Quarterly) stood at -$17,000 in 2023, then tumbled by 2,335.29% to -$414,000 in 2024, then crashed by 121.05% to -$42,000 in 2025.
  • Its Revenue stands at -$42,000 for Q3 2025, versus -$74,000 for Q2 2025 and -$80,000 for Q1 2025.